Fundraising Fox
Lir
2 known investors
Find your way into Lir
Sign up to see every warm intro you have to Lir
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lir team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.
Founders & leadership
KH
Killian HanlonCo-founderKillian Hanlon is co-founder and CEO of Lir Therapeutics, a gene therapy company developing AI-driven optimization of viral vectors. His prior research, documented in peer-reviewed publications, focused on molecular and genetic engineering.
Investors · 2
Frequently asked questions
- What does Lir do?
- Lir develops AI-driven viral vector engineering for gene therapy, using machine learning to optimize AAV (adeno-associated virus) vectors for improved dose efficiency, tissue targeting, and immune evasion.
- Who founded Lir?
- Lir was founded by Killian Hanlon, Hugh O'Brien.
- Who are Lir's investors?
- Lir's investors include Amino Collective, Fly Ventures.